MED PHARMA TRADING DMCC has a pharmacovigilance system to monitor the safety of medicinal products. In accordance with international standards and pharmacovigilance legislation, the system ensures the implementation of all necessary measures for the safe use of medicines.
Proper quality of medicines does not guarantee that adverse events or side effects will not occur, which are caused by the pharmacological properties of the drug components or the body's response to its administration. Pharmacovigilance addresses these issues. Pharmacovigilance allows for safety monitoring throughout the entire lifecycle of medicines (both during development and after market release). Analyzing the information obtained enables timely detection of changes in the benefit/risk balance, minimizing side effects or reducing their impact. Risk minimization measures help patients receive the most optimal treatment. That is why any information about the safety of MED PHARMA TRADING DMCC's medicines is very important to us!
If you become aware of:
- a side effect; - lack of therapeutic effect; - overdose, misuse, off-label use, medical errors, or effects related to professional activity; - transmission of infection through a medicinal product; - use of medicines during pregnancy or breastfeeding; - effects on the embryo or fetus (after maternal use or via transmission through the father's sperm); - unexpected therapeutic effect; - interactions with other medicines; - suspected side effects related to quality defects or counterfeit medicines of MED PHARMA TRADING DMCC, please inform us by any convenient method listed below.
It is important to include in your report:
1. Information about the person reporting the issue (name, phone number, email, qualification: e.g., doctor or non-medical worker). 2. Information about the person who used the medicine (initials, age, gender, etc.). 3. Information about the medicine used (brand name, dosage, treatment period, batch number (mandatory for biological products), etc.). 4. Description of the problem related to the medicine use (side effect and/or other safety issue). If you do not have all the data, please provide any information you know that may be related to the use of MED PHARMA TRADING DMCC's medicine.
Contact details for reporting in the Republic of Kazakhstan:
Phone: +7 771 101 18 98 E-mail: phv@pharmavist.kz *Reports are accepted based on duly executed contractual relations by the authorized person responsible for pharmacovigilance (QPPV) at MED PHARMA TRADING DMCC. You can report safety issues by filling out the forms: Consumer Adverse Reaction Reporting Form and Healthcare Professional Adverse Reaction Reporting Form. Before reporting an adverse reaction, please review the Privacy Policy, which grants permission to process your/patient personal data to the extent necessary for pharmacovigilance.
